Travere Therapeutics, Inc. (TVTX)
47.52
+1.71
(+3.73%)
USD |
NASDAQ |
Jun 08, 13:34
Travere Therapeutics Shareholders Equity (Quarterly) : 98.73M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -6.656B |
| Mirum Pharmaceuticals, Inc. | 242.49M |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Inovio Pharmaceuticals, Inc. | 6.068M |
| Insmed, Inc. | 704.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 555.19M |
| Total Liabilities (Quarterly) | 456.46M |
| Debt to Equity Ratio | 3.319 |
| Current Ratio | 3.130 |
| Net Debt Paydown Yield | 0.54% |